Related references
Note: Only part of the references are listed.FXR activation improves myocardial fatty acid metabolism in a rodent model of obesity-driven cardiotoxicity
A. Mencarelli et al.
NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES (2013)
Ursodeoxycholic Acid in Patients With Chronic Heart Failure A Double-Blind, Randomized, Placebo-Controlled, Crossover Trial
Stephan von Haehling et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2012)
FXR Protects Lung from Lipopolysaccharide-Induced Acute Injury
Lisheng Zhang et al.
MOLECULAR ENDOCRINOLOGY (2012)
Dimethylarginine Dimethylaminohydrolase-1 Is the Critical Enzyme for Degrading the Cardiovascular Risk Factor Asymmetrical Dimethylarginine
Xinli Hu et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2011)
Dimethylarginine Dimethylaminohydrolase 1 Modulates Endothelial Cell Growth Through Nitric Oxide and Akt
Ping Zhang et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2011)
Bile Acids as Regulators of Hepatic Lipid and Glucose Metabolism
Michael Trauner et al.
DIGESTIVE DISEASES (2010)
Vascular Endothelial-Specific Dimethylarginine Dimethylaminohydrolase-1-Deficient Mice Reveal That Vascular Endothelium Plays an Important Role in Removing Asymmetric Dimethylarginine
Xinli Hu et al.
CIRCULATION (2009)
Plasma Asymmetric Dimethylarginine and Incidence of Cardiovascular Disease and Death in the Community
Rainer H. Boeger et al.
CIRCULATION (2009)
Bile acids as regulatory molecules
Phillip B. Hylemon et al.
JOURNAL OF LIPID RESEARCH (2009)
Coordinated Regulation of Dimethylarginine Dimethylaminohydrolase-1 and Cationic Amino Acid Transporter-1 by Farnesoid X Receptor in Mouse Liver and Kidney and Its Implication in the Control of Blood Levels of Asymmetric Dimethylarginine
Jiang Li et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2009)
Impairment of endothelial nitric oxide synthase causes abnormal fat and glycogen deposition in liver
Lorenz Schild et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2008)
Phosphorylation of endothelial nitric-oxide synthase regulates superoxide generation from the enzyme
Chun-An Chen et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Ursodeoxycholic acid: Mechanism of action and novel clinical applications
Tadashi Ikegami et al.
HEPATOLOGY RESEARCH (2008)
Metabolic profiling of arginine and nitric oxide pathways predicts hemodynamic abnormalities and mortality in patients with cardiogenic shock after acute myocardial infarction
Stephen J. Nicholls et al.
CIRCULATION (2007)
Cardiomyocyte-restricted restoration of nitric oxide synthase 3 attenuates left ventricular remodeling after chronic pressure overload
Emmanuel S. Buys et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2007)
Effect of asymmetric dimethylarginine on atherogenesis deformability in apolipoprotein E deficient and erythrocyte mice
Hong-Bo Xiao et al.
LIFE SCIENCES (2007)
Asymmetric dimethylarginine induces oxidative and nitrosative stress in murine lung epithelial cells
Sandra M. Wells et al.
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2007)
Inducible nitric oxide synthase deficiency protects the heart from systolic overload-induced ventricular hypertrophy and congestive heart failure
Ping Zhang et al.
CIRCULATION RESEARCH (2007)
Asymmetrical dimethylarginine inhibits shear stress-induced nitric oxide release and dilation and elicits superoxide-mediated increase in arteriolar tone
Janos Toth et al.
HYPERTENSION (2007)
Disruption of methylarginine metabolism impairs vascular homeostasis
James Leiper et al.
NATURE MEDICINE (2007)
Evidence for the pathophysiological role of endogenous methylarginines in regulation of endothelial NO production and vascular function
Arturo J. Cardounel et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Farnesoid X receptor agonist reduces serum asymmetric dimethylarginine levels through hepatic dimethylarginine dimethylaminohydrolase-1 gene regulation
Tonghuan Hu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Chemical chaperones reduce ER stress and restore glucose homeostasis in a mouse model of type 2 diabetes
Umut Oezcan et al.
SCIENCE (2006)
Farnesoid X receptor is essential for normal glucose homeostasis
K Ma et al.
JOURNAL OF CLINICAL INVESTIGATION (2006)
Dimethylarginine dimethylaminohydrolase and endothelial dysfunction in failing hearts
YJ Chen et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2005)
Neuronal nitric oxide synthase controls enzyme activity pattern of mitochondria and lipid metabolism
L Schild et al.
FASEB JOURNAL (2005)
Concentric left ventricular remodeling in endothelial nitric oxide synthase knockout mice by chronic pressure overload
H Ruetten et al.
CARDIOVASCULAR RESEARCH (2005)
Oxidant stress from nitric oxide synthase-3 uncoupling stimulates cardiac pathologic remodeling from chronic pressure load
E Takimoto et al.
JOURNAL OF CLINICAL INVESTIGATION (2005)
Endogenous methylarginines modulate superoxide as well as nitric oxide generation from neuronal nitric-oxide synthase - Differences in the effects of monomethyl- and dimethylarginines in the presence and absence of tetrahydrobiopterin
AJ Cardounel et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Insulin resistance: potential role of the endogenous nitric oxide synthase inhibitor ADMA
K Sydow et al.
VASCULAR MEDICINE (2005)
Premature death and age-related cardiac dysfunction in male eNOS-knockout mice
W Li et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2004)
Cardiomyocyte-specific overexpression of nitric oxide synthase 3 improves left ventricular performance and reduces compensatory hypertrophy after myocardial infarction
S Janssens et al.
CIRCULATION RESEARCH (2004)
Endogenous nitric oxide synthesis inhibitor asymmetric dimethyl L-arginine accelerates endothelial cell senescence
F Scalera et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2004)
Dimethylarginine dimethylaminohydrolase regulates nitric oxide synthesis - Genetic and physiological evidence
H Dayoub et al.
CIRCULATION (2003)
Combined loss of neuronal and endothelial nitric oxide synthase causes premature mortality and age-related hypertrophic cardiac remodeling in mice
LA Barouch et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2003)
Endogenous nitric oxide synthase inhibitors and renal perfusion in patients with heart failure
JT Kielstein et al.
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION (2003)
Endothelial nitric oxide synthase overexpression attenuates congestive heart failure in mice
SP Jones et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Oxidation of tetrahydrobiopterin leads to uncoupling of endothelial cell nitric oxide synthase in hypertension
U Landmesser et al.
JOURNAL OF CLINICAL INVESTIGATION (2003)
Metabolism of asymmetric dimethylarginines is regulated in the lung developmentally and with pulmonary hypertension induced by hypobaric hypoxia
FI Arrigoni et al.
CIRCULATION (2003)
Nitric oxide modulates myocardial oxygen consumption in the failing heart
YJ Chen et al.
CIRCULATION (2002)
Oxidation of the zinc-thiolate complex and uncoupling of endothelial nitric oxide synthase by peroxynitrite
MH Zou et al.
JOURNAL OF CLINICAL INVESTIGATION (2002)
Cardiomyocyte overexpression of iNOS in mice results in peroxynitrite generation, heart block, and sudden death
IN Mungrue et al.
JOURNAL OF CLINICAL INVESTIGATION (2002)
Endothelial nitric oxide synthase limits left ventricular remodeling after myocardial infarction in mice
M Scherrer-Crosbie et al.
CIRCULATION (2001)
An endogenous inhibitor of nitric oxide synthase regulates endothelial adhesiveness for monocytes
RH Böger et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2000)
Targeted disruption of the nuclear receptor FXR/BAR impairs bile acid and lipid homeostasis
CJ Sinal et al.
CELL (2000)
Chromosomal localization, gene structure, and expression pattern of DDAH1:: Comparison with DDAH2 and implications for evolutionary origins
CTL Tran et al.
GENOMICS (2000)
Identification of a chemical tool for the orphan nuclear receptor FXR
PR Maloney et al.
JOURNAL OF MEDICINAL CHEMISTRY (2000)
Share Paper
